These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 19276138

  • 1. Initial therapy in multiple myeloma: investigating the new treatment paradigm.
    Kettle JK, Finkbiner KL, Klenke SE, Baker RD, Henry DW, Williams CB.
    J Oncol Pharm Pract; 2009 Sep; 15(3):131-41. PubMed ID: 19276138
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Emerging drugs in multiple myeloma.
    Ghobrial IM, Leleu X, Hatjiharissi E, Hideshima T, Mitsiades C, Schlossman R, Anderson KC, Richardson P.
    Expert Opin Emerg Drugs; 2007 Mar; 12(1):155-63. PubMed ID: 17355220
    [Abstract] [Full Text] [Related]

  • 7. Treatment of multiple myeloma: an emphasis on new developments.
    Kyle RA, Vincent Rajkumar S.
    Ann Med; 2006 Mar; 38(2):111-5. PubMed ID: 16581696
    [Abstract] [Full Text] [Related]

  • 8. New developments in the treatment of patients with multiple myeloma.
    Minnema MC, van der Spek E, van de Donk NW, Lokhorst HM.
    Neth J Med; 2010 Jan; 68(1):24-32. PubMed ID: 20103818
    [Abstract] [Full Text] [Related]

  • 9. Advances in therapy of multiple myeloma.
    Bladé J, Rosiñol L.
    Curr Opin Oncol; 2008 Nov; 20(6):697-704. PubMed ID: 18841053
    [Abstract] [Full Text] [Related]

  • 10. Management of older patients with multiple myeloma.
    Gay F, Palumbo A.
    Blood Rev; 2011 Mar; 25(2):65-73. PubMed ID: 21295387
    [Abstract] [Full Text] [Related]

  • 11. Management of multiple myeloma with bortezomib: experts review the data and debate the issues.
    Dicato M, Boccadoro M, Cavenagh J, Harousseau JL, Ludwig H, San Miguel J, Sonneveld P.
    Oncology; 2006 Mar; 70(6):474-82. PubMed ID: 17283449
    [Abstract] [Full Text] [Related]

  • 12. New drugs for myeloma.
    Richardson PG, Mitsiades C, Schlossman R, Munshi N, Anderson K.
    Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058
    [Abstract] [Full Text] [Related]

  • 13. Novel agents for relapsed and/or refractory multiple myeloma.
    Thomas SK, Richards TA, Weber DM.
    Cancer J; 2009 Jun; 15(6):485-93. PubMed ID: 20010168
    [Abstract] [Full Text] [Related]

  • 14. Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.
    Laubach JP, Schlossman RL, Mitsiades CS, Anderson KC, Richardson PG.
    Expert Rev Hematol; 2011 Feb; 4(1):51-60. PubMed ID: 21322778
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical management of myeloma--state of the art.
    Harousseau JL.
    Cancer Treat Rev; 2010 May; 36 Suppl 2():S1-2. PubMed ID: 20472182
    [Abstract] [Full Text] [Related]

  • 17. New drugs for multiple myeloma.
    Anderson KC.
    Clin Adv Hematol Oncol; 2006 Aug; 4(8):592-4. PubMed ID: 17099617
    [No Abstract] [Full Text] [Related]

  • 18. Frontline therapy for multiple myeloma: a concise review of the evidence based on randomized clinical trials.
    Yaqub S, Ballester G, Ballester O.
    Cancer Invest; 2013 Oct; 31(8):529-37. PubMed ID: 24083815
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Novel therapies in myeloma.
    Hayden PJ, Mitsiades CS, Anderson KC, Richardson PG.
    Curr Opin Hematol; 2007 Nov; 14(6):609-15. PubMed ID: 17898564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.